Publications by authors named "Eva Altmann"

Claim this Profile
R
Ring systems in medicinal chemistry: A cheminformatics analysis of ring popularity in drug discovery over time.
Peter Ertl, Eva Altmann, Rainer Wilcken

Eur J Med Chem· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hormone-mediated disassembly and inactivation of a plant E3 ubiquitin ligase complex.
Cristina Martínez, Elisa Iniesto, Marta García-León, Daniel García-Corredera, Sandra Fonseca, Eva Altmann

Cell Rep· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to "MicroCycle: An Integrated and Automated Platform to Accelerate Drug Discovery".
Cara E Brocklehurst, Eva Altmann, Jérôme André, Corentin Bon, Thomas Caya

J Med Chem· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroCycle: An Integrated and Automated Platform to Accelerate Drug Discovery.
Cara E Brocklehurst, Eva Altmann, Corentin Bon, Holly Davis, David Dunstan

J Med Chem· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Which boronic acids are used most frequently for synthesis of bioactive molecules?
Peter Ertl, Eva Altmann, Sophie Racine, Odile Decoret

Bioorg Med Chem· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and Biochemical Characterization of Peptidic Inhibitors of the Myb/p300 Interaction.
Matthew Jones, Philipp Grosche, Andreas Floersheimer, Jérome André, Raphael Gattlen, Eva Altmann

Biochemistry· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The most common linkers in bioactive molecules and their bioisosteric replacement network.
Peter Ertl, Eva Altmann, Sophie Racine

Bioorg Med Chem· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Ring replacement recommender: Ring modifications for improving biological activity.
Peter Ertl, Eva Altmann, Sophie Racine, Richard Lewis

Eur J Med Chem· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of Potent, Highly Selective, and Efficacious, Allosteric MALT1 Inhibitors by Iterative Scaffold Morphing.
Carole Pissot Soldermann, Oliver Simic, Martin Renatus, Paulus Erbel, Samu Melkko, Eva Altmann

J Med Chem· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-Based Design and Preclinical Characterization of Selective and Orally Bioavailable Factor XIa Inhibitors: Demonstrating the Power of an Integrated S1 Protease Family Approach.
Edwige Lorthiois, James Roache, David Barnes-Seeman, Eva Altmann, Ulrich Hassiepen

J Med Chem· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Most Common Functional Groups in Bioactive Molecules and How Their Popularity Has Evolved over Time.
Peter Ertl, Eva Altmann, Jeffrey M McKenna

J Med Chem· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural Basis of Substrate Recognition and Covalent Inhibition of Cdu1 from Chlamydia trachomatis.
Yesid A Ramirez, Thomas B Adler, Eva Altmann, Theresa Klemm, Christian Tiesmeyer

ChemMedChem· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Azaindoles as Zinc-Binding Small-Molecule Inhibitors of the JAMM Protease CSN5.
Eva Altmann, Paul Erbel, Martin Renatus, Michael Schaefer, Anita Schlierf

Angew Chem Int Ed Engl· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted inhibition of the COP9 signalosome for treatment of cancer.
Anita Schlierf, Eva Altmann, Jean Quancard, Anne B Jefferson, René Assenberg

Nat Commun· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-based design and optimization of potent inhibitors of the adenoviral protease.
Philipp Grosche, Finton Sirockin, Aengus Mac Sweeney, Paul Ramage, Paul Erbel, Eva Altmann

Bioorg Med Chem Lett· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and structure-based optimization of adenain inhibitors.
Aengus Mac Sweeney, Philipp Grosche, David Ellis, Keith Combrink, Paul Erbel, Eva Altmann

ACS Med Chem Lett· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Penta-substituted benzimidazoles as potent antagonists of the calcium-sensing receptor (CaSR-antagonists).
Marc Gerspacher, Eva Altmann, René Beerli, Thomas Buhl, Ralf Endres

Bioorg Med Chem Lett· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1-Alkyl-4-phenyl-6-alkoxy-1H-quinazolin-2-ones: a novel series of potent calcium-sensing receptor antagonists.
Leo Widler, Eva Altmann, René Beerli, Werner Breitenstein, Rochdi Bouhelal

J Med Chem· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2-Cyano-pyrimidines: a new chemotype for inhibitors of the cysteine protease cathepsin K.
Eva Altmann, Reiner Aichholz, Claudia Betschart, Thomas Buhl, Jonathan Green

J Med Chem· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dipeptide nitrile inhibitors of cathepsin K.
Eva Altmann, Reiner Aichholz, Claudia Betschart, Thomas Buhl, Jonathan Green

Bioorg Med Chem Lett· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel purine nitrile derived inhibitors of the cysteine protease cathepsin K.
Eva Altmann, Sandra W Cowan-Jacob, Martin Missbach

J Med Chem· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arylaminoethyl amides as inhibitors of the cysteine protease cathepsin K-investigating P1' substituents.
Eva Altmann, Jonathan Green, Marina Tintelnot-Blomley

Bioorg Med Chem Lett· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complementary use of ion trap/time-of-flight mass spectrometry in combination with capillary high-pressure liquid chromatography: early characterization of in vivo metabolites of the cathepsin K inhibitor NVP-AAV490 in rat.
Wolfgang Blum, Thomas Buhl, Eva Altmann, Jürgen Kühnöl, Philippe Ramstein

J Chromatogr B Analyt Technol Biomed Life Sci· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arylaminoethyl amides as novel non-covalent cathepsin K inhibitors.
Eva Altmann, Johanne Renaud, Jonathan Green, David Farley, Brian Cutting

J Med Chem· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N(7)-substituted-5-aryl-pyrrolo[2,3-d]pyrimidines represent a versatile class of potent inhibitors of the tyrosine kinase c-Src.
Eva Altmann, Leo Widler, Martin Missbach

Mini Rev Med Chem· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis